Trial Profile
Retrospective study to compare the effectiveness of two alternate therapies, tenofovir disoproxil fumarate(TDF) monotherapy and combination therapy of Entecavir+tenofovir disoproxil fumarate in chronic hepatitis B patients.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 05 Apr 2016
Price :
$35
*
At a glance
- Drugs Entecavir (Primary) ; Tenofovir disoproxil fumarate (Primary)
- Indications Hepatitis B
- Focus Therapeutic Use
- 05 Apr 2016 New trial record